Clin2
NCT07786389Possibly a fitEnrolling by invitation

Seaweed supplement for ulcerative colitis inflammation

Ulcerative Colitis (UC)

Part of Digestive system clinical trials.

This study tests whether a supplement made from seaweed (fucoidan) can help reduce gut inflammation in people with mild to moderate ulcerative colitis. If you join, you'll take the supplement and have your symptoms and blood levels checked.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
90 people
Ages
18 years to 64 years
Study type
Interventional

Who can take part

  • You are between 18 and 64 years old.
  • You have been diagnosed with mild to moderate ulcerative colitis.
  • You do not have other autoimmune or chronic diseases, bleeding disorders, severe infections, or organ failure.
  • You are not taking certain medications like steroids, immunosuppressants, or herbal treatments.
  • You are not allergic to soy or seaweed, and you are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07650942Not yet recruiting· Phase 3
Study drug for moderate to severe ulcerative colitis

This trial tests an oral study drug called Hemay005 for people with moderate to severe ulcerative colitis (UC) who have not responded well to other treatments. If you join, you will receive either the study drug or a placebo (inactive pill) to see if it helps reduce symptoms and heal the gut lining.

Guangzhou
NCT06895252Recruiting
Fecal transplant and diet for new ulcerative colitis

This study tests whether a combination of fecal transplant (transferring healthy stool into your gut) and dietary changes can help control inflammation in people recently diagnosed with active ulcerative colitis. It may offer a new treatment option before starting stronger medications.

Kochi, Kerala
NCT07619638Not yet recruiting
Microbiome Supplement for Mild-to-Moderate Ulcerative Colitis

This trial tests a specially designed supplement that aims to restore healthy gut bacteria in people with mild-to-moderate ulcerative colitis. The goal is to reduce inflammation and improve symptoms like rectal bleeding and bowel urgency.

Izmir
NCT07744646Not yet recruiting· Phase 1
Test of a new daily pill for moderate-to-severe ulcerative colitis

This study tests an investigational pill for people with moderate-to-severe ulcerative colitis that has not improved with standard treatments. The goal is to see if the pill can reduce symptoms like bloody stools and frequent bowel movements.

Hefei, Anhui
NCT07335055Recruiting· Phase 2
Testing HSK47388 for moderate to severe ulcerative colitis

This study tests an experimental drug called HSK47388 for people with moderate to severe ulcerative colitis who have not had good results from other treatments. The goal is to see if it can reduce inflammation and improve symptoms.

Hangzhou
NCT07427017Recruiting· Phase 2
Selenium for Ulcerative Colitis Patients on Biologics

This trial tests whether taking selenium supplements can help people with moderate to severe ulcerative colitis that is being treated with advanced therapies (biologics). The goal is to see if selenium can improve symptoms and reduce inflammation.

Chicago, Illinois

Hear when a new Ulcerative Colitis (UC) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.